Search
Search Results
##search.searchResults.foundPlural##
-
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2143PDF: 916HTML: 55 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6649PDF: 3539HTML: 718 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1254PDF: 1078HTML: 89 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2175PDF: 877HTML: 283 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3225PDF: 1424HTML: 3970 -
-
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3167PDF: 876HTML: 744text and figure: 206 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3408PDF: 1571HTML: 2660 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2154PDF: 1001HTML: 1970Characteristic of study group: 175 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2055PDF: 1365HTML: 671 -
-
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1599PDF: 697HTML: 2326 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2702PDF: 719HTML: 1240Blood Count trend before and during lenalidomide treatment: 149Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 166 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2004PDF: 1000HTML: 15639COVER LETTER: 163 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2795PDF: 1387HTML: 3037Cover Letter: 180 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
9924PDF: 938HTML: 191 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5039PDF: 1286HTML: 2721Cover letter: 173 -
How I treat acute and persistent sickle cell pain
1818PDF: 1077HTML: 456 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2229PDF: 1537HTML: 571 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1454PDF: 756HTML: 1458Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 160 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2115PDF: 912HTML: 2143 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2074PDF: 722HTML: 1015Spirometry in SCA patients before transplant: 178Spirometry in SCA patients post transplant: 161 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3800PDF: 1428HTML: 9169Untitled: 255Untitled: 158Untitled: 148Untitled: 143Untitled: 162Untitled: 315







